CYP51A1 and tuberculosis: We identified multiple drugs for treatment of TB, malaria, and HIV but because of the lack of treatments for kinetoplastid infection, only two for Chagas disease were identified (both of these were triazole inhibitors of CYP51 that failed in the clinic) and none for VL (SI Appendix, Table S1).